Open AccessProposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis
Author(s) -
Kathryn Fleming,
A John Ashcroft,
Christopher Alexakis,
Demitrios Tzias,
Christopher J. Groves,
Andrew Poullis
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i11.3376
Subject(s) - mesalazine , ulcerative colitis , medicine , context (archaeology) , cardiogenic shock , inflammatory bowel disease , cardiomyopathy , gastroenterology , adverse effect , colitis , disease , heart failure , paleontology , myocardial infarction , biology
Five-amino salicylic acids are recommended for use in the management of inflammatory bowel disease, cardiac complications are a rare although recognised phenomenon. This report aims to highlight this serious but rare adverse reaction. We report here a case of a young man presenting with cardiogenic shock in the context of recent mesalazine treatment in severe ulcerative colitis.